Concept嵌合抗原受体T细胞疗法
CAR-T
A cellular immunotherapy in which a patient's T cells are genetically engineered to express a chimeric antigen receptor, enabling them to specifically recognize and kill tumor cells.
Timeline (last 90 days)
Oct 30
Expert review judged 37 CAR-T hypotheses as both novel and biologically plausible.
Unverified50%